Patents by Inventor Zhongzhi Wu

Zhongzhi Wu has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR MAKING COVER PLATE, COVER PLATE AND ELECTRONIC DEVICE
    Publication number: 20240090151
    Abstract: A method for making a cover plate, a cover plate and an electronic device. The method for making the cover plate includes: disposing a light-shielding material on a periphery of a first light-transmitting material and a periphery of a second light-transmitting material; squeezing the first light-transmitting material, the second light-transmitting material and the light-shielding material to obtain a composite rod material; and treating the composite rod material to obtain the cover plate.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 14, 2024
    Applicant: GUANGDONG OPPO MOBILE TELECOMMUNICATIONS CORP., LTD.
    Inventors: Feng XU, Zimei YANG, Zhongzhi TANG, Jianwen LIN, Yingchao WU
  • QUINOLINE DERIVATIVES AND USES IN MANAGING CANCER
    Publication number: 20240059658
    Abstract: Provided herein are compounds, pharmaceutical compositions including such compounds, and methods of using such compounds to treat diseases or disorders associated with MDM2 activity.
    Type: Application
    Filed: September 10, 2020
    Publication date: February 22, 2024
    Inventors: Muxiang Zhou, Lubing Gu, We Li, Zhongzhi Wu
  • METABOLICALLY STABLE PYRIMIDINYL DIHYDROQUINOXALINONES AS TUBULIN POLYMERIZATION INHIBITORS
    Publication number: 20230286995
    Abstract: The invention encompasses novel dihydroquinoxalinone compounds with significantly improved water solubility and reduced toxicity to achieve higher therapeutic indexes and the treatment of cancer, virus infections, and inflammation using the same.
    Type: Application
    Filed: April 20, 2022
    Publication date: September 14, 2023
    Inventors: Souvik BANERJEE, Shanshan DENG, Wei LI, K A Foyez MAHMUD, Duane D. MILLER, Zhongzhi WU, Rui WANG, Tiffany SEAGROVES, Raisa KRUTILINA, Kelli HARTMANN, Satyanarayana POCHAMPALLY
  • TRANSIENT RECEPTOR POTENTIAL CANONICAL 3 INHIBITORS AND METHODS OF USE THEREOF
    Publication number: 20230265068
    Abstract: Provided herein are compounds, pharmaceutical compositions comprising such compounds, and methods of using such compounds to treat diseases or disorders associated with TRPC3 activity.
    Type: Application
    Filed: April 12, 2023
    Publication date: August 24, 2023
    Applicant: University of Tennessee Research Foundation
    Inventors: Wei Li, Julio Cordero-Morales, Jianxiong Jiang, Zhongzhi Wu, Francesca Liao, Catherine Kaczorowski
  • Estrogen receptor ligands and methods of use thereof
    Patent number: 9409856
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBA compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including, inter alia, prevention and treatment of hormone-related diseases, cancers, inflammation, osteoporosis, peripheral vascular disease, reducing circulating lipid levels, and cardiovascular disease.
    Type: Grant
    Filed: June 8, 2015
    Date of Patent: August 9, 2016
    Assignee: Gtx, Inc.
    Inventors: James T. Dalton, Christina Herring, Duane D. Miller, Seoung-Soo Hong, Yali He, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • ESTROGEN RECEPTOR LIGANDS AND METHODS OF USE THEREOF
    Publication number: 20160031797
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBA compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including, inter alia, prevention and treatment of hormone-related diseases, cancers, inflammation, osteoporosis, peripheral vascular disease, reducing circulating lipid levels, and cardiovascular disease.
    Type: Application
    Filed: June 8, 2015
    Publication date: February 4, 2016
    Inventors: James T. DALTON, Christina Herring, Duane D. MILLER, Seoung-Soo HONG, Yali HE, Michael L. MOHLER, Ramesh NARAYANAN, Zhongzhi WU
  • Nuclear receptor binding agents
    Patent number: 9078888
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
    Type: Grant
    Filed: January 22, 2008
    Date of Patent: July 14, 2015
    Assignee: GTX, INC.
    Inventors: James T. Dalton, Duane D. Miller, Michael L. Mohler, Seoung-Soo Hong, Zhongzhi Wu, Devesh Srivastava
  • Nuclear receptor binding agents
    Patent number: 8637706
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Grant
    Filed: January 31, 2012
    Date of Patent: January 28, 2014
    Assignee: Gtx, Inc.
    Inventors: James T. Dalton, Christina Barrett, Duane D. Miller, Seoung-Soo Hong, Yali He, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • ALDO-KETO REDUCTASE SUBFAMILY 1C3 (AKR1C3) INHIBITORS
    Publication number: 20130116277
    Abstract: The present invention relates to a novel class of AKR1C3 inhibitors, to compositions containing them, to methods for their preparation, and to methods of use thereof. The AKR1C3 inhibitors may be useful in the treatment of, for example, prostate cancer, benign prostate hyperplasia (BPH), lung cancer, acne, seborrhea, hirsuitism, baldness, alopecia, precocious puberty, adrenal hypertrophy, polycystic ovary syndrome, breast cancer, uterine cancer, uterine fibroids, endometriosis, myeloma and leiomyoma.
    Type: Application
    Filed: September 7, 2012
    Publication date: May 9, 2013
    Inventors: James T. DALTON, Duane D. Miller, Ramesh Narayanan, Muralimohan Yepuru, Christopher C. Coss, Michael L. Mohler, Zhongzhi Wu
  • NUCLEAR RECEPTOR BINDING AGENTS
    Publication number: 20120157539
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: January 31, 2012
    Publication date: June 21, 2012
    Inventors: James T. DALTON, Christina BARRETT, Duane D. MILLER, Seoung-Soo HONG, Yali HE, Michael L. MOHLER, Ramesh NARAYANAN, Zhongzhi WU
  • Nuclear receptor binding agents
    Patent number: 8158828
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Grant
    Filed: April 16, 2007
    Date of Patent: April 17, 2012
    Assignee: GTx, Inc.
    Inventors: James T. Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane D. Miller, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • Nuclear receptor binding agents
    Publication number: 20090062341
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: November 28, 2006
    Publication date: March 5, 2009
    Inventors: James T. Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane D. Miller, Michael L. Mohler, Ramesh Narayanan, Zhongzhi Wu
  • Nuclear receptor binding agents
    Publication number: 20090030036
    Abstract: The present invention relates to a novel class of nuclear receptor binding agents (NRBAs). The NRBAs are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, inflammatory diseases, oxidative stress related disorders such as Parkinson's and stroke, neurological disorders, ophthalamic disorders, cardiovascular disease, and obesity.
    Type: Application
    Filed: January 22, 2008
    Publication date: January 29, 2009
    Inventors: James T. Dalton, Duane D. Miller, Michael L. Mohler, Seoung-Soo Hong, Zhongzhi Wu, Devesh Srivastava
  • Nuclear receptor binding agents
    Publication number: 20070265296
    Abstract: The present invention relates to a novel class of selective estrogen receptor modulators (SERMs). The SERM compounds are applicable for use in the prevention and/or treatment of a variety of diseases and conditions including prevention and treatment of cancers such as prostate and breast cancer, osteoporosis, hormone-related diseases, hot flashes or vasomotor symptoms, neurological disorders, cardiovascular disease and obesity.
    Type: Application
    Filed: April 16, 2007
    Publication date: November 15, 2007
    Inventors: James Dalton, Christina Barrett, Yali He, Seoung-Soo Hong, Duane Miller, Michael Mohler, Ramesh Narayanan, Zhongzhi Wu